These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm. Cao J; Gillberg JM; Swerdlow CD Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074 [TBL] [Abstract][Full Text] [Related]
30. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Schmitt C; Montero M; Melichercik J Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854 [TBL] [Abstract][Full Text] [Related]
31. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death]. Kozák M; Krivan L; Semrád B Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881 [TBL] [Abstract][Full Text] [Related]
32. Is it safe to program a long tachycardia detection interval? Kühlkamp V; Dörnberger V; Bosch RR; Kettering K; Mewis C J Cardiovasc Electrophysiol; 2002 Nov; 13(11):1169-72. PubMed ID: 12475111 [TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A; Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511 [TBL] [Abstract][Full Text] [Related]
34. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis. Hook BG; Callans DJ; Kleiman RB; Flores BT; Marchlinski FE Circulation; 1993 Jun; 87(6):1897-906. PubMed ID: 8504502 [TBL] [Abstract][Full Text] [Related]
36. A case of exhaustion of implantable cardioverter defibrillator therapies due to inappropriate programming. Fragakis NK; Antoniadis AP; Geleris P Hellenic J Cardiol; 2011; 52(4):354-6. PubMed ID: 21933768 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
38. A new classification algorithm for discrimination of ventricular from supraventricular tachycardia in a dual chamber implantable cardioverter defibrillator. Korte T; Jung W; Wolpert C; Spehl S; Schumacher B; Esmailzadeh B; Lüderitz B J Cardiovasc Electrophysiol; 1998 Jan; 9(1):70-3. PubMed ID: 9475579 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of a dual chamber implantable cardioverter defibrillator capable of slow ventricular tachycardia discrimination: a randomized study. Mletzko R; Aliot E; Seidl K; Lavergne T; Mabo P; Hohnloser S; Bocker D; Schoels W; Sadoul N Pacing Clin Electrophysiol; 2003 Dec; 26(12):2275-82. PubMed ID: 14675012 [TBL] [Abstract][Full Text] [Related]
40. Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias. Volosin K; Stadler RW; Wyszynski R; Kirchhof P Europace; 2013 Aug; 15(8):1215-22. PubMed ID: 23439867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]